| Control | EP | |
---|---|---|---|
CT (copies/ml) | Single infection | (n = 1) | (n = 6) |
6.06 X106 | 2.45 X 107 ± 1.43 X 105 | ||
Co-infections | (n = 2) | ( n = 17) | |
4.19 X 106 ± 2.98 X 106 | 4.22 X107 ± 2.1 X107 | ||
NG (copies/ml) | Single infection | ND | ND |
Co-infections | (n = 1) | (n = 5) | |
6.24 X 104 | 7.9 X 105 ± 2.08 X 105 | ||
MG (copies/ml) | Single infection | ND | (n = 2) 5.23 X 106 ± 2.13 X106 |
Co-infections | (n = 2) | (n = 14) | |
3.1 X 106 ± 1.98 X105 | 9.67 X 106 ± 3.35 X107 | ||
U. Urea/Parv (copies/ml) | Single infection | (n = 1) | (n = 2) |
2.2 X107 | 7.54 X107 ± 3.54 X 107 | ||
Co-infections | (n = 3) | (n = 7) | |
1.58 X107 ± 0.88 X107 | 9.87 X107 ± 2.15 X 107 | ||
GV (copies/ml) | Single infection | ND | ND |
Co-infections | (n = 1) | (n = 6) | |
3.89 X106 | 11.95 X107 ± 5.38 X 107 | ||
TV (copies/ml) | Single infection | ND | ND |
Co-infections | ND | (n = 3) | |
1.38 X106 ± 0.71 X 106 | |||
HSV-1/2 (copies/ml) | Single infection | ND | (n = 1) |
3.05 X104 | |||
Co-infections | (n = 3) | (n = 17) | |
3.34 X104 ± 1.41 X104 | 2.90 X105 ± 9.41 X104 |